| 0 |
PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC |
98 |
0.4100 |
| 1 |
PANCREATIC NEUROENDOCRINE TUMOUR |
177 |
0.2761 |
| 2 |
SMOOTH MUSCLE CELL NEOPLASM |
103 |
0.2464 |
| 3 |
POLYOMAVIRUS VIRAEMIA |
241 |
0.2269 |
| 4 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
507 |
0.2162 |
| 5 |
PIK3CA-ACTIVATED MUTATION |
71 |
0.2139 |
| 6 |
ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING |
42 |
0.1772 |
| 7 |
BLOOD CHROMOGRANIN A INCREASED |
75 |
0.1634 |
| 8 |
NEUROENDOCRINE TUMOUR |
227 |
0.1602 |
| 9 |
HUMAN POLYOMAVIRUS INFECTION |
78 |
0.1469 |
| 10 |
MYCOBACTERIUM HAEMOPHILUM INFECTION |
40 |
0.1399 |
| 11 |
BK VIRUS INFECTION |
454 |
0.1345 |
| 12 |
METASTASES TO SKIN |
136 |
0.1317 |
| 13 |
CHRONIC ALLOGRAFT NEPHROPATHY |
102 |
0.1303 |
| 14 |
VIRAEMIA |
168 |
0.1212 |
| 15 |
HUMAN HERPESVIRUS 8 INFECTION |
73 |
0.1199 |
| 16 |
LUNG TRANSPLANT REJECTION |
76 |
0.1152 |
| 17 |
LYMPHOCELE |
76 |
0.1145 |
| 18 |
METASTASES TO THE MEDIASTINUM |
46 |
0.1117 |
| 19 |
MICROSPORIDIA INFECTION |
39 |
0.1111 |
| 20 |
METASTASES TO CHEST WALL |
36 |
0.1037 |
| 21 |
METASTASES TO PLEURA |
106 |
0.1010 |
| 22 |
PARVOVIRUS B19 INFECTION |
89 |
0.0994 |
| 23 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
495 |
0.0972 |
| 24 |
TRICHODYSPLASIA SPINULOSA |
37 |
0.0971 |
| 25 |
HEART TRANSPLANT REJECTION |
100 |
0.0963 |
| 26 |
LIVER TRANSPLANT REJECTION |
170 |
0.0945 |
| 27 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
86 |
0.0929 |
| 28 |
TRANSPLANT REJECTION |
713 |
0.0889 |
| 29 |
CARBOHYDRATE ANTIGEN 15-3 INCREASED |
66 |
0.0867 |
| 30 |
ALVEOLAR PROTEINOSIS |
51 |
0.0861 |
| 31 |
METASTASES TO PANCREAS |
37 |
0.0835 |
| 32 |
RENAL TUBULAR ATROPHY |
72 |
0.0816 |
| 33 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
96 |
0.0800 |
| 34 |
KIDNEY FIBROSIS |
137 |
0.0789 |
| 35 |
METASTATIC RENAL CELL CARCINOMA |
144 |
0.0786 |
| 36 |
EPSTEIN-BARR VIRAEMIA |
86 |
0.0775 |
| 37 |
METASTASES TO ABDOMINAL CAVITY |
38 |
0.0772 |
| 38 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
100 |
0.0759 |
| 39 |
CRYPTOSPORIDIOSIS INFECTION |
39 |
0.0743 |
| 40 |
MALACOPLAKIA |
34 |
0.0742 |
| 41 |
METASTASES TO LIVER |
1302 |
0.0740 |
| 42 |
CHRONIC GRAFT VERSUS HOST DISEASE |
265 |
0.0733 |
| 43 |
LYMPHANGIOSIS CARCINOMATOSA |
76 |
0.0729 |
| 44 |
CELL MARKER INCREASED |
34 |
0.0710 |
| 45 |
BREAST CANCER METASTATIC |
730 |
0.0679 |
| 46 |
THROMBOTIC MICROANGIOPATHY |
657 |
0.0674 |
| 47 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
53 |
0.0673 |
| 48 |
GRAFT VERSUS HOST DISEASE IN LIVER |
48 |
0.0670 |
| 49 |
GRAFT LOSS |
48 |
0.0662 |
| 50 |
ADENOVIRUS INFECTION |
191 |
0.0658 |
| 51 |
METASTASES TO BONE |
1073 |
0.0653 |
| 52 |
METASTASES TO ADRENALS |
60 |
0.0650 |
| 53 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
147 |
0.0648 |
| 54 |
CARCINOID TUMOUR |
48 |
0.0645 |
| 55 |
GASTRIC ANTRAL VASCULAR ECTASIA |
34 |
0.0643 |
| 56 |
METASTASES TO LUNG |
735 |
0.0636 |
| 57 |
EPSTEIN-BARR VIRUS INFECTION |
396 |
0.0633 |
| 58 |
HEPATITIS E |
100 |
0.0633 |
| 59 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
207 |
0.0626 |
| 60 |
GRAFT VERSUS HOST DISEASE IN SKIN |
136 |
0.0617 |
| 61 |
KIDNEY TRANSPLANT REJECTION |
296 |
0.0616 |
| 62 |
METASTASES TO SPINE |
207 |
0.0615 |
| 63 |
RENAL TRANSPLANT FAILURE |
59 |
0.0597 |
| 64 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
126 |
0.0592 |
| 65 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
250 |
0.0565 |
| 66 |
TUMOUR MARKER INCREASED |
268 |
0.0558 |
| 67 |
STOMATITIS |
3387 |
0.0558 |
| 68 |
TRANSPLANT FAILURE |
131 |
0.0534 |
| 69 |
METASTASES TO LYMPH NODES |
353 |
0.0522 |
| 70 |
DELAYED GRAFT FUNCTION |
37 |
0.0520 |
| 71 |
TRANSITIONAL CELL CARCINOMA |
66 |
0.0508 |
| 72 |
PNEUMOCYSTIS JIROVECII INFECTION |
60 |
0.0502 |
| 73 |
HEPATIC LESION |
217 |
0.0501 |
| 74 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
70 |
0.0495 |
| 75 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
35 |
0.0487 |
| 76 |
RENAL TUBULAR INJURY |
59 |
0.0486 |
| 77 |
TUMOUR PAIN |
64 |
0.0486 |
| 78 |
PNEUMONITIS |
1307 |
0.0480 |
| 79 |
METASTASES TO PERITONEUM |
120 |
0.0475 |
| 80 |
ACUTE GRAFT VERSUS HOST DISEASE |
217 |
0.0474 |
| 81 |
MALIGNANT NEOPLASM PROGRESSION |
4801 |
0.0468 |
| 82 |
RENAL CANCER METASTATIC |
36 |
0.0468 |
| 83 |
CONCOMITANT DISEASE PROGRESSION |
91 |
0.0465 |
| 84 |
ONCOLOGIC COMPLICATION |
44 |
0.0455 |
| 85 |
CYTOMEGALOVIRUS VIRAEMIA |
200 |
0.0449 |
| 86 |
JC VIRUS INFECTION |
71 |
0.0444 |
| 87 |
HYPERTRIGLYCERIDAEMIA |
258 |
0.0440 |
| 88 |
INTUSSUSCEPTION |
42 |
0.0440 |
| 89 |
CYTOMEGALOVIRUS COLITIS |
99 |
0.0430 |
| 90 |
APHTHOUS ULCER |
333 |
0.0429 |
| 91 |
TRANSPLANT DYSFUNCTION |
76 |
0.0426 |
| 92 |
CYTOMEGALOVIRUS INFECTION |
675 |
0.0406 |
| 93 |
PNEUMONIA CYTOMEGALOVIRAL |
78 |
0.0401 |
| 94 |
RENAL CELL CARCINOMA |
193 |
0.0394 |
| 95 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
109 |
0.0394 |
| 96 |
TUMOUR NECROSIS |
41 |
0.0388 |
| 97 |
MOUTH ULCERATION |
810 |
0.0384 |
| 98 |
OBLITERATIVE BRONCHIOLITIS |
49 |
0.0373 |
| 99 |
DEVICE RELATED THROMBOSIS |
36 |
0.0365 |
| 100 |
HUMAN HERPESVIRUS 6 INFECTION |
69 |
0.0365 |
| 101 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
63 |
0.0356 |
| 102 |
ORAL PAIN |
787 |
0.0351 |
| 103 |
BILE DUCT STENOSIS |
42 |
0.0350 |
| 104 |
MALIGNANT PLEURAL EFFUSION |
59 |
0.0350 |
| 105 |
VARICELLA ZOSTER VIRUS INFECTION |
70 |
0.0337 |
| 106 |
MUCOSAL INFLAMMATION |
883 |
0.0337 |
| 107 |
HEPATIC NEOPLASM |
109 |
0.0334 |
| 108 |
GRAFT VERSUS HOST DISEASE |
240 |
0.0333 |
| 109 |
BONE LESION |
118 |
0.0327 |
| 110 |
SQUAMOUS CELL CARCINOMA OF SKIN |
197 |
0.0326 |
| 111 |
METASTASIS |
232 |
0.0325 |
| 112 |
NEOPLASM PROGRESSION |
1059 |
0.0304 |
| 113 |
BREAST CANCER RECURRENT |
95 |
0.0300 |
| 114 |
SECOND PRIMARY MALIGNANCY |
248 |
0.0298 |
| 115 |
ENCEPHALITIS VIRAL |
36 |
0.0296 |
| 116 |
APHTHOUS STOMATITIS |
68 |
0.0294 |
| 117 |
LYMPHADENOPATHY MEDIASTINAL |
56 |
0.0292 |
| 118 |
LUNG INFILTRATION |
256 |
0.0290 |
| 119 |
PNEUMONIA PSEUDOMONAL |
44 |
0.0287 |
| 120 |
MEAN CELL HAEMOGLOBIN DECREASED |
51 |
0.0278 |
| 121 |
LUNG CONSOLIDATION |
77 |
0.0275 |
| 122 |
GASTROENTERITIS NOROVIRUS |
36 |
0.0271 |
| 123 |
MOUTH INJURY |
41 |
0.0270 |
| 124 |
HEPATIC MASS |
52 |
0.0270 |
| 125 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
43 |
0.0268 |
| 126 |
HAEMOLYTIC URAEMIC SYNDROME |
62 |
0.0267 |
| 127 |
PYELONEPHRITIS ACUTE |
52 |
0.0265 |
| 128 |
LYMPHOEDEMA |
181 |
0.0261 |
| 129 |
CYTOMEGALOVIRUS TEST POSITIVE |
46 |
0.0258 |
| 130 |
NEPHROPATHY TOXIC |
288 |
0.0256 |
| 131 |
IGA NEPHROPATHY |
42 |
0.0253 |
| 132 |
NOROVIRUS INFECTION |
36 |
0.0249 |
| 133 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
250 |
0.0249 |
| 134 |
KLEBSIELLA INFECTION |
124 |
0.0245 |
| 135 |
BRONCHOPULMONARY ASPERGILLOSIS |
188 |
0.0242 |
| 136 |
NONINFECTIVE GINGIVITIS |
35 |
0.0242 |
| 137 |
PULMONARY TOXICITY |
169 |
0.0239 |
| 138 |
DRUG LEVEL DECREASED |
243 |
0.0239 |
| 139 |
NOCARDIOSIS |
61 |
0.0238 |
| 140 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
306 |
0.0237 |
| 141 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
45 |
0.0232 |
| 142 |
PAPILLOMA VIRAL INFECTION |
38 |
0.0230 |
| 143 |
ACTINIC KERATOSIS |
59 |
0.0227 |
| 144 |
ENTEROCOCCAL INFECTION |
108 |
0.0223 |
| 145 |
BACTERIAL SEPSIS |
72 |
0.0221 |
| 146 |
ESCHERICHIA SEPSIS |
64 |
0.0221 |
| 147 |
INVASIVE DUCTAL BREAST CARCINOMA |
60 |
0.0221 |
| 148 |
ENTEROBACTER INFECTION |
37 |
0.0220 |
| 149 |
CHOLANGITIS |
136 |
0.0219 |
| 150 |
ORGANISING PNEUMONIA |
108 |
0.0218 |
| 151 |
PROTEINURIA |
414 |
0.0218 |
| 152 |
LINEAR IGA DISEASE |
36 |
0.0216 |
| 153 |
LIVER ABSCESS |
70 |
0.0216 |
| 154 |
CONCOMITANT DISEASE AGGRAVATED |
132 |
0.0214 |
| 155 |
SOFT TISSUE INFECTION |
39 |
0.0213 |
| 156 |
CANCER PAIN |
54 |
0.0211 |
| 157 |
DYSLIPIDAEMIA |
107 |
0.0210 |
| 158 |
CACHEXIA |
108 |
0.0210 |
| 159 |
RECURRENT CANCER |
85 |
0.0208 |
| 160 |
PNEUMONIA KLEBSIELLA |
38 |
0.0207 |
| 161 |
NEOPLASM |
236 |
0.0205 |
| 162 |
RENAL MASS |
42 |
0.0204 |
| 163 |
PLEURAL EFFUSION |
1234 |
0.0203 |
| 164 |
RENAL NEOPLASM |
43 |
0.0202 |
| 165 |
DRUG LEVEL INCREASED |
333 |
0.0201 |
| 166 |
ASCITES |
584 |
0.0198 |
| 167 |
ESCHERICHIA INFECTION |
162 |
0.0197 |
| 168 |
CREPITATIONS |
58 |
0.0195 |
| 169 |
METASTASES TO MENINGES |
44 |
0.0193 |
| 170 |
PSEUDOMONAS INFECTION |
164 |
0.0191 |
| 171 |
CYTOMEGALOVIRUS CHORIORETINITIS |
37 |
0.0190 |
| 172 |
BRAIN ABSCESS |
48 |
0.0189 |
| 173 |
PNEUMATOSIS INTESTINALIS |
54 |
0.0189 |
| 174 |
TONGUE ULCERATION |
63 |
0.0186 |
| 175 |
BILE DUCT OBSTRUCTION |
35 |
0.0184 |
| 176 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
176 |
0.0184 |
| 177 |
BODY TEMPERATURE DECREASED |
181 |
0.0184 |
| 178 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
47 |
0.0177 |
| 179 |
HYPERGLYCAEMIA |
644 |
0.0177 |
| 180 |
EXPOSED BONE IN JAW |
38 |
0.0175 |
| 181 |
INTERSTITIAL LUNG DISEASE |
848 |
0.0175 |
| 182 |
OSTEONECROSIS OF JAW |
427 |
0.0172 |
| 183 |
HYPERLIPIDAEMIA |
206 |
0.0172 |
| 184 |
HYPERCHOLESTEROLAEMIA |
166 |
0.0172 |
| 185 |
HYPOPHOSPHATAEMIA |
127 |
0.0172 |
| 186 |
ONYCHOCLASIS |
118 |
0.0171 |
| 187 |
RENAL TUBULAR NECROSIS |
168 |
0.0171 |
| 188 |
INGROWING NAIL |
40 |
0.0169 |
| 189 |
ASPERGILLUS INFECTION |
111 |
0.0169 |
| 190 |
LIPIDS INCREASED |
34 |
0.0168 |
| 191 |
VENOOCCLUSIVE DISEASE |
42 |
0.0168 |
| 192 |
PNEUMONIA FUNGAL |
66 |
0.0167 |
| 193 |
METASTATIC NEOPLASM |
72 |
0.0167 |
| 194 |
BLOOD CREATININE DECREASED |
52 |
0.0166 |
| 195 |
APLASIA PURE RED CELL |
57 |
0.0166 |
| 196 |
BLOOD PRESSURE SYSTOLIC INCREASED |
319 |
0.0163 |
| 197 |
NAIL DISORDER |
143 |
0.0163 |
| 198 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
258 |
0.0163 |
| 199 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
461 |
0.0163 |
| 200 |
BLOOD TRIGLYCERIDES INCREASED |
287 |
0.0162 |
| 201 |
CYSTITIS HAEMORRHAGIC |
65 |
0.0161 |
| 202 |
ODYNOPHAGIA |
96 |
0.0161 |
| 203 |
HYDRONEPHROSIS |
118 |
0.0157 |
| 204 |
ESCHERICHIA URINARY TRACT INFECTION |
66 |
0.0155 |
| 205 |
HYPOGAMMAGLOBULINAEMIA |
102 |
0.0155 |
| 206 |
GLOMERULONEPHRITIS |
38 |
0.0155 |
| 207 |
BLOOD CREATININE ABNORMAL |
53 |
0.0153 |
| 208 |
DRUG LEVEL ABOVE THERAPEUTIC |
70 |
0.0153 |
| 209 |
DISEASE PROGRESSION |
1805 |
0.0152 |
| 210 |
BONE CANCER |
65 |
0.0149 |
| 211 |
ESCHERICHIA BACTERAEMIA |
35 |
0.0149 |
| 212 |
EATING DISORDER |
316 |
0.0148 |
| 213 |
PERICARDIAL EFFUSION |
343 |
0.0148 |
| 214 |
ORTHOPNOEA |
47 |
0.0147 |
| 215 |
LUNG NEOPLASM |
63 |
0.0147 |
| 216 |
BLOOD CREATININE INCREASED |
962 |
0.0147 |
| 217 |
URINARY TRACT INFECTION BACTERIAL |
37 |
0.0146 |
| 218 |
HEPATIC PAIN |
62 |
0.0145 |
| 219 |
DRUG LEVEL BELOW THERAPEUTIC |
80 |
0.0145 |
| 220 |
PROTEIN TOTAL DECREASED |
54 |
0.0143 |
| 221 |
SQUAMOUS CELL CARCINOMA |
134 |
0.0142 |
| 222 |
THERAPY PARTIAL RESPONDER |
219 |
0.0140 |
| 223 |
SCLERODERMA |
51 |
0.0140 |
| 224 |
HERPES SIMPLEX |
91 |
0.0140 |
| 225 |
VENOOCCLUSIVE LIVER DISEASE |
69 |
0.0140 |
| 226 |
PORTAL HYPERTENSION |
43 |
0.0139 |
| 227 |
SKIN TOXICITY |
78 |
0.0138 |
| 228 |
APLASTIC ANAEMIA |
72 |
0.0138 |
| 229 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
321 |
0.0138 |
| 230 |
PNEUMONIA BACTERIAL |
124 |
0.0135 |
| 231 |
ORAL DISORDER |
99 |
0.0135 |
| 232 |
ENTERITIS |
86 |
0.0134 |
| 233 |
BLOOD PHOSPHORUS DECREASED |
49 |
0.0134 |
| 234 |
PULMONARY MASS |
199 |
0.0133 |
| 235 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
40 |
0.0133 |
| 236 |
RHINOVIRUS INFECTION |
51 |
0.0131 |
| 237 |
RALES |
76 |
0.0131 |
| 238 |
WOUND DEHISCENCE |
44 |
0.0130 |
| 239 |
LYMPHOPENIA |
184 |
0.0130 |
| 240 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
286 |
0.0129 |
| 241 |
BLOOD ALBUMIN DECREASED |
102 |
0.0128 |
| 242 |
AZOTAEMIA |
51 |
0.0128 |
| 243 |
ATELECTASIS |
123 |
0.0127 |
| 244 |
NEPHROTIC SYNDROME |
86 |
0.0125 |
| 245 |
LARGE INTESTINAL ULCER |
34 |
0.0125 |
| 246 |
DERMATITIS ACNEIFORM |
76 |
0.0125 |
| 247 |
BLOOD PRESSURE DIASTOLIC DECREASED |
90 |
0.0122 |
| 248 |
RENAL IMPAIRMENT |
1015 |
0.0121 |
| 249 |
PORTAL VEIN THROMBOSIS |
39 |
0.0121 |
| 250 |
DRUG RESISTANCE |
310 |
0.0121 |
| 251 |
GINGIVAL PAIN |
96 |
0.0120 |
| 252 |
NEOPLASM MALIGNANT |
805 |
0.0120 |
| 253 |
BACTERIAL INFECTION |
225 |
0.0120 |
| 254 |
FEEDING DISORDER |
244 |
0.0120 |
| 255 |
BLOOD UREA INCREASED |
201 |
0.0120 |
| 256 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
90 |
0.0120 |
| 257 |
BONE MARROW DISORDER |
36 |
0.0119 |
| 258 |
GINGIVITIS |
64 |
0.0119 |
| 259 |
LUNG DISORDER |
578 |
0.0118 |
| 260 |
GINGIVAL SWELLING |
52 |
0.0118 |
| 261 |
HYPERURICAEMIA |
48 |
0.0117 |
| 262 |
CHEILITIS |
63 |
0.0116 |
| 263 |
LYMPHOCYTE COUNT DECREASED |
205 |
0.0116 |
| 264 |
HYPOALBUMINAEMIA |
90 |
0.0116 |
| 265 |
PNEUMOTHORAX |
183 |
0.0115 |
| 266 |
URINE OUTPUT DECREASED |
100 |
0.0114 |
| 267 |
C-REACTIVE PROTEIN INCREASED |
416 |
0.0114 |
| 268 |
GLOMERULAR FILTRATION RATE DECREASED |
140 |
0.0114 |
| 269 |
HEPATIC FIBROSIS |
39 |
0.0114 |
| 270 |
PYELONEPHRITIS |
98 |
0.0113 |
| 271 |
HYPOPHAGIA |
288 |
0.0113 |
| 272 |
PULMONARY ALVEOLAR HAEMORRHAGE |
63 |
0.0112 |
| 273 |
SPINAL PAIN |
131 |
0.0112 |
| 274 |
HEPATOCELLULAR CARCINOMA |
85 |
0.0112 |
| 275 |
SEPTIC SHOCK |
486 |
0.0112 |
| 276 |
PERFORMANCE STATUS DECREASED |
52 |
0.0111 |
| 277 |
IMMUNE THROMBOCYTOPENIA |
51 |
0.0111 |
| 278 |
ENCEPHALITIS |
77 |
0.0111 |
| 279 |
HYPERVOLAEMIA |
55 |
0.0111 |
| 280 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
38 |
0.0111 |
| 281 |
DUODENITIS |
34 |
0.0111 |
| 282 |
BLOOD CHOLESTEROL INCREASED |
516 |
0.0111 |
| 283 |
PATHOLOGICAL FRACTURE |
56 |
0.0110 |
| 284 |
DIASTOLIC DYSFUNCTION |
34 |
0.0110 |
| 285 |
HYPERCALCAEMIA |
136 |
0.0110 |
| 286 |
PNEUMONIA VIRAL |
35 |
0.0110 |
| 287 |
EPISTAXIS |
816 |
0.0109 |
| 288 |
INJECTION SITE HYPERSENSITIVITY |
34 |
0.0109 |
| 289 |
UROSEPSIS |
100 |
0.0108 |
| 290 |
CHAPPED LIPS |
47 |
0.0108 |
| 291 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
38 |
0.0108 |
| 292 |
CYTOPENIA |
132 |
0.0108 |
| 293 |
DIFFUSE LARGE B-CELL LYMPHOMA |
83 |
0.0108 |
| 294 |
BLOOD CREATINE INCREASED |
47 |
0.0106 |
| 295 |
NECROSIS |
59 |
0.0106 |
| 296 |
FAILURE TO THRIVE |
55 |
0.0106 |
| 297 |
RED CELL DISTRIBUTION WIDTH INCREASED |
44 |
0.0106 |
| 298 |
LEUKOPENIA |
526 |
0.0105 |
| 299 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
185 |
0.0104 |
| 300 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
258 |
0.0104 |
| 301 |
ABDOMINAL HERNIA |
47 |
0.0103 |
| 302 |
LUNG INFECTION |
159 |
0.0102 |
| 303 |
PROTEIN URINE PRESENT |
51 |
0.0102 |
| 304 |
HAEMATOTOXICITY |
97 |
0.0102 |
| 305 |
IMMUNOSUPPRESSION |
90 |
0.0102 |
| 306 |
JAUNDICE CHOLESTATIC |
36 |
0.0102 |
| 307 |
HEPATITIS B |
61 |
0.0101 |
| 308 |
SKIN MASS |
67 |
0.0100 |
| 309 |
GENERALISED OEDEMA |
124 |
0.0100 |
| 310 |
BLOOD PRESSURE DIASTOLIC INCREASED |
46 |
0.0100 |
| 311 |
VENOUS THROMBOSIS |
39 |
0.0099 |
| 312 |
TERMINAL STATE |
66 |
0.0099 |
| 313 |
BLOOD MAGNESIUM DECREASED |
85 |
0.0098 |
| 314 |
COVID-19 PNEUMONIA |
116 |
0.0098 |
| 315 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1134 |
0.0098 |
| 316 |
PARONYCHIA |
43 |
0.0098 |
| 317 |
CARDIOPULMONARY FAILURE |
38 |
0.0097 |
| 318 |
MALNUTRITION |
109 |
0.0097 |
| 319 |
DECREASED APPETITE |
2246 |
0.0097 |
| 320 |
HEPATOMEGALY |
93 |
0.0095 |
| 321 |
GASTROENTERITIS |
138 |
0.0094 |
| 322 |
THROMBOCYTOPENIA |
1056 |
0.0094 |
| 323 |
OEDEMA PERIPHERAL |
1141 |
0.0094 |
| 324 |
ERYSIPELAS |
47 |
0.0093 |
| 325 |
PULMONARY HAEMORRHAGE |
73 |
0.0093 |
| 326 |
RESPIRATORY FAILURE |
673 |
0.0092 |
| 327 |
AMYLASE INCREASED |
34 |
0.0092 |
| 328 |
MOUTH SWELLING |
53 |
0.0092 |
| 329 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
35 |
0.0092 |
| 330 |
SUSPECTED OFF LABEL USE |
41 |
0.0091 |
| 331 |
OESOPHAGEAL CANDIDIASIS |
36 |
0.0090 |
| 332 |
BRAIN NEOPLASM |
83 |
0.0090 |
| 333 |
DECREASED IMMUNE RESPONSIVENESS |
88 |
0.0090 |
| 334 |
GASTROINTESTINAL TOXICITY |
43 |
0.0089 |
| 335 |
DEHYDRATION |
1193 |
0.0089 |
| 336 |
POLYNEUROPATHY |
107 |
0.0089 |
| 337 |
HAEMOGLOBIN DECREASED |
917 |
0.0089 |
| 338 |
TENDERNESS |
93 |
0.0089 |
| 339 |
PULMONARY OEDEMA |
399 |
0.0089 |
| 340 |
NAIL DISCOLOURATION |
35 |
0.0089 |
| 341 |
CANDIDA INFECTION |
150 |
0.0089 |
| 342 |
SHOCK HAEMORRHAGIC |
72 |
0.0088 |
| 343 |
BLOOD CALCIUM DECREASED |
99 |
0.0088 |
| 344 |
ANAEMIA |
1675 |
0.0088 |
| 345 |
ELECTROLYTE IMBALANCE |
102 |
0.0088 |
| 346 |
APHAGIA |
42 |
0.0087 |
| 347 |
MUSCULOSKELETAL CHEST PAIN |
135 |
0.0087 |
| 348 |
OVARIAN CYST |
87 |
0.0087 |
| 349 |
HAEMATOCRIT DECREASED |
172 |
0.0087 |
| 350 |
HYPOXIA |
305 |
0.0087 |
| 351 |
OEDEMA |
466 |
0.0086 |
| 352 |
ORAL HERPES |
166 |
0.0085 |
| 353 |
TRANSAMINASES INCREASED |
189 |
0.0085 |
| 354 |
GLOSSODYNIA |
190 |
0.0085 |
| 355 |
ACUTE RESPIRATORY FAILURE |
163 |
0.0085 |
| 356 |
AORTIC VALVE INCOMPETENCE |
36 |
0.0085 |
| 357 |
MULTI-ORGAN FAILURE |
145 |
0.0084 |
| 358 |
TASTE DISORDER |
170 |
0.0084 |
| 359 |
NEPHROPATHY |
78 |
0.0083 |
| 360 |
BONE MARROW FAILURE |
169 |
0.0083 |
| 361 |
PANCYTOPENIA |
463 |
0.0083 |
| 362 |
THERAPY CHANGE |
81 |
0.0082 |
| 363 |
IMPAIRED HEALING |
270 |
0.0082 |
| 364 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
50 |
0.0082 |
| 365 |
ENTEROCOLITIS |
47 |
0.0081 |
| 366 |
SMALL INTESTINAL OBSTRUCTION |
100 |
0.0081 |
| 367 |
YELLOW SKIN |
38 |
0.0081 |
| 368 |
BACTERAEMIA |
96 |
0.0081 |
| 369 |
PROCTALGIA |
52 |
0.0081 |
| 370 |
LARGE INTESTINE PERFORATION |
56 |
0.0081 |
| 371 |
RENAL CYST |
64 |
0.0081 |
| 372 |
LYMPHADENOPATHY |
284 |
0.0080 |
| 373 |
PLATELET COUNT DECREASED |
855 |
0.0080 |
| 374 |
ANURIA |
69 |
0.0080 |
| 375 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
66 |
0.0080 |
| 376 |
ABDOMINAL ABSCESS |
35 |
0.0079 |
| 377 |
SKIN NECROSIS |
41 |
0.0079 |
| 378 |
PRODUCT USE IN UNAPPROVED INDICATION |
1958 |
0.0079 |
| 379 |
MASS |
110 |
0.0079 |
| 380 |
BOWEL MOVEMENT IRREGULARITY |
60 |
0.0078 |
| 381 |
HERPES VIRUS INFECTION |
45 |
0.0078 |
| 382 |
PYREXIA |
2703 |
0.0078 |
| 383 |
ILEUS |
97 |
0.0078 |
| 384 |
ENDOCARDITIS |
40 |
0.0078 |
| 385 |
OESOPHAGITIS |
85 |
0.0078 |
| 386 |
DEATH |
6689 |
0.0078 |
| 387 |
CLOSTRIDIUM DIFFICILE COLITIS |
82 |
0.0077 |
| 388 |
DIARRHOEA HAEMORRHAGIC |
72 |
0.0077 |
| 389 |
ORAL DISCOMFORT |
107 |
0.0077 |
| 390 |
BLOOD POTASSIUM INCREASED |
125 |
0.0077 |
| 391 |
ULCER |
122 |
0.0077 |
| 392 |
SKIN LESION |
210 |
0.0076 |
| 393 |
BLOOD CALCIUM INCREASED |
67 |
0.0076 |
| 394 |
ACUTE KIDNEY INJURY |
1169 |
0.0076 |
| 395 |
CHOLECYSTITIS |
91 |
0.0076 |
| 396 |
LEFT VENTRICULAR DYSFUNCTION |
51 |
0.0076 |
| 397 |
HYPOCALCAEMIA |
144 |
0.0076 |
| 398 |
DIABETES MELLITUS |
579 |
0.0076 |
| 399 |
FLUID INTAKE REDUCED |
38 |
0.0076 |
| 400 |
RED BLOOD CELL COUNT DECREASED |
217 |
0.0076 |
| 401 |
PATHOGEN RESISTANCE |
69 |
0.0076 |
| 402 |
WEIGHT DECREASED |
2108 |
0.0075 |
| 403 |
HEPATIC ENCEPHALOPATHY |
70 |
0.0075 |
| 404 |
HOSPICE CARE |
74 |
0.0075 |
| 405 |
FLANK PAIN |
70 |
0.0075 |
| 406 |
POLYURIA |
61 |
0.0074 |
| 407 |
BREAST CANCER |
694 |
0.0074 |
| 408 |
BONE PAIN |
432 |
0.0074 |
| 409 |
DRUG INTOLERANCE |
712 |
0.0074 |
| 410 |
HEPATIC FAILURE |
222 |
0.0074 |
| 411 |
COUGH |
2060 |
0.0073 |
| 412 |
HYPOKALAEMIA |
338 |
0.0073 |
| 413 |
BASAL CELL CARCINOMA |
114 |
0.0073 |
| 414 |
HYPOVOLAEMIC SHOCK |
35 |
0.0073 |
| 415 |
BLOOD URIC ACID INCREASED |
42 |
0.0073 |
| 416 |
SEPSIS |
808 |
0.0072 |
| 417 |
DUODENAL ULCER |
51 |
0.0072 |
| 418 |
DIARRHOEA |
4641 |
0.0072 |
| 419 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
394 |
0.0072 |
| 420 |
CLOSTRIDIUM DIFFICILE INFECTION |
156 |
0.0071 |
| 421 |
ACUTE PULMONARY OEDEMA |
40 |
0.0071 |
| 422 |
PIGMENTATION DISORDER |
44 |
0.0071 |
| 423 |
HAEMOLYSIS |
55 |
0.0071 |
| 424 |
DRUG INTERACTION |
1129 |
0.0071 |
| 425 |
OLIGURIA |
44 |
0.0071 |
| 426 |
PARTIAL SEIZURES |
37 |
0.0071 |
| 427 |
NODULE |
92 |
0.0070 |
| 428 |
BLOOD PRESSURE INCREASED |
1074 |
0.0070 |
| 429 |
ASPARTATE AMINOTRANSFERASE INCREASED |
373 |
0.0070 |
| 430 |
HEPATIC ENZYME ABNORMAL |
35 |
0.0070 |
| 431 |
ACNE |
532 |
0.0070 |
| 432 |
TOOTHACHE |
127 |
0.0070 |
| 433 |
GASTRITIS |
183 |
0.0069 |
| 434 |
RENAL DISORDER |
324 |
0.0069 |
| 435 |
FURUNCLE |
55 |
0.0069 |
| 436 |
GASTROENTERITIS VIRAL |
125 |
0.0069 |
| 437 |
RESPIRATORY DISTRESS |
190 |
0.0069 |
| 438 |
NEUTROPENIA |
933 |
0.0069 |
| 439 |
INTESTINAL PERFORATION |
77 |
0.0069 |
| 440 |
BLOOD SODIUM DECREASED |
129 |
0.0068 |
| 441 |
PULMONARY CONGESTION |
90 |
0.0068 |
| 442 |
CHOLESTASIS |
131 |
0.0068 |
| 443 |
PNEUMONIA |
2207 |
0.0068 |
| 444 |
SKIN ULCER |
176 |
0.0068 |
| 445 |
MITRAL VALVE INCOMPETENCE |
77 |
0.0068 |
| 446 |
VIRAL INFECTION |
225 |
0.0068 |
| 447 |
EJECTION FRACTION DECREASED |
105 |
0.0067 |
| 448 |
METABOLIC DISORDER |
39 |
0.0067 |
| 449 |
CHOLECYSTITIS ACUTE |
38 |
0.0067 |
| 450 |
BRONCHIECTASIS |
45 |
0.0067 |
| 451 |
LIPASE INCREASED |
51 |
0.0066 |
| 452 |
GENERAL PHYSICAL CONDITION ABNORMAL |
45 |
0.0066 |
| 453 |
RENAL PAIN |
70 |
0.0066 |
| 454 |
SKIN INFECTION |
74 |
0.0066 |
| 455 |
THERAPY NON-RESPONDER |
296 |
0.0066 |
| 456 |
PLEURISY |
39 |
0.0066 |
| 457 |
BLOOD POTASSIUM DECREASED |
197 |
0.0065 |
| 458 |
EYELID OEDEMA |
76 |
0.0065 |
| 459 |
HEPATIC FUNCTION ABNORMAL |
244 |
0.0065 |
| 460 |
DYSPNOEA EXERTIONAL |
246 |
0.0065 |
| 461 |
SEIZURE |
754 |
0.0065 |
| 462 |
RENAL FAILURE |
857 |
0.0064 |
| 463 |
RHINITIS |
52 |
0.0064 |
| 464 |
PHARYNGITIS |
80 |
0.0064 |
| 465 |
INTESTINAL OBSTRUCTION |
243 |
0.0064 |
| 466 |
MOUTH HAEMORRHAGE |
47 |
0.0064 |
| 467 |
COLITIS |
243 |
0.0064 |
| 468 |
PAPULE |
45 |
0.0064 |
| 469 |
NASAL DRYNESS |
40 |
0.0064 |
| 470 |
DYSGEUSIA |
474 |
0.0064 |
| 471 |
AGEUSIA |
159 |
0.0064 |
| 472 |
FEBRILE NEUTROPENIA |
421 |
0.0063 |
| 473 |
HAEMOPTYSIS |
176 |
0.0063 |
| 474 |
PLATELET COUNT INCREASED |
82 |
0.0063 |
| 475 |
SKIN PLAQUE |
53 |
0.0063 |
| 476 |
BREAST MASS |
42 |
0.0062 |
| 477 |
JAUNDICE |
168 |
0.0062 |
| 478 |
PERIPHERAL SWELLING |
958 |
0.0062 |
| 479 |
TRICUSPID VALVE INCOMPETENCE |
49 |
0.0062 |
| 480 |
CARDIAC FAILURE ACUTE |
41 |
0.0061 |
| 481 |
GASTROINTESTINAL INFECTION |
55 |
0.0061 |
| 482 |
ALANINE AMINOTRANSFERASE INCREASED |
376 |
0.0061 |
| 483 |
BLOOD URINE PRESENT |
116 |
0.0061 |
| 484 |
HYPOMAGNESAEMIA |
85 |
0.0061 |
| 485 |
INFLAMMATION |
311 |
0.0060 |
| 486 |
INFECTION |
872 |
0.0060 |
| 487 |
GASTROINTESTINAL INFLAMMATION |
47 |
0.0060 |
| 488 |
FACIAL PARALYSIS |
51 |
0.0060 |
| 489 |
BODY TEMPERATURE INCREASED |
122 |
0.0060 |
| 490 |
LIVER DISORDER |
265 |
0.0060 |
| 491 |
STAPHYLOCOCCAL INFECTION |
197 |
0.0060 |
| 492 |
TACHYPNOEA |
81 |
0.0060 |
| 493 |
POSTOPERATIVE WOUND INFECTION |
40 |
0.0059 |
| 494 |
GROIN PAIN |
52 |
0.0059 |
| 495 |
MYOPATHY |
51 |
0.0059 |
| 496 |
CARDIOMEGALY |
72 |
0.0058 |
| 497 |
HEPATOTOXICITY |
130 |
0.0058 |
| 498 |
RESPIRATORY TRACT INFECTION |
152 |
0.0058 |
| 499 |
BREAST PAIN |
62 |
0.0058 |
| 500 |
HYPOVOLAEMIA |
34 |
0.0058 |
| 501 |
EMBOLISM |
48 |
0.0058 |
| 502 |
LIVER FUNCTION TEST ABNORMAL |
168 |
0.0058 |
| 503 |
ABDOMINAL PAIN |
1343 |
0.0058 |
| 504 |
NEEDLE ISSUE |
168 |
0.0058 |
| 505 |
RETINAL DETACHMENT |
53 |
0.0058 |
| 506 |
IRON DEFICIENCY ANAEMIA |
53 |
0.0057 |
| 507 |
IMMUNODEFICIENCY |
85 |
0.0057 |
| 508 |
COAGULOPATHY |
95 |
0.0057 |
| 509 |
BRAIN OEDEMA |
72 |
0.0057 |
| 510 |
ORAL CANDIDIASIS |
75 |
0.0057 |
| 511 |
LOW DENSITY LIPOPROTEIN INCREASED |
44 |
0.0057 |
| 512 |
PRODUCTIVE COUGH |
269 |
0.0056 |
| 513 |
HEPATITIS C |
68 |
0.0056 |
| 514 |
GASTRIC ULCER |
107 |
0.0056 |
| 515 |
RASH PUSTULAR |
41 |
0.0056 |
| 516 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
49 |
0.0056 |
| 517 |
ABNORMAL FAECES |
46 |
0.0056 |
| 518 |
RENAL FAILURE ACUTE |
238 |
0.0056 |
| 519 |
CORONAVIRUS INFECTION |
37 |
0.0056 |
| 520 |
BLOOD BILIRUBIN INCREASED |
151 |
0.0056 |
| 521 |
APPETITE DISORDER |
37 |
0.0056 |
| 522 |
SPINAL COMPRESSION FRACTURE |
46 |
0.0056 |
| 523 |
HYPERTENSION |
1177 |
0.0056 |
| 524 |
LIVER FUNCTION TEST INCREASED |
119 |
0.0055 |
| 525 |
CELLULITIS |
279 |
0.0055 |
| 526 |
RESPIRATORY RATE INCREASED |
49 |
0.0055 |
| 527 |
ASPHYXIA |
45 |
0.0055 |
| 528 |
HEPATITIS |
141 |
0.0055 |
| 529 |
HYPERBILIRUBINAEMIA |
57 |
0.0055 |
| 530 |
ASTHENIA |
2067 |
0.0055 |
| 531 |
CHOLELITHIASIS |
180 |
0.0055 |
| 532 |
NEUTROPHIL COUNT INCREASED |
56 |
0.0055 |
| 533 |
TOOTH INFECTION |
72 |
0.0055 |
| 534 |
DERMATITIS |
114 |
0.0054 |
| 535 |
NEUROTOXICITY |
95 |
0.0054 |
| 536 |
ECCHYMOSIS |
37 |
0.0054 |
| 537 |
VITAMIN D DECREASED |
46 |
0.0054 |
| 538 |
CARDIAC FAILURE |
431 |
0.0054 |
| 539 |
ADRENAL INSUFFICIENCY |
65 |
0.0054 |
| 540 |
TOXICITY TO VARIOUS AGENTS |
903 |
0.0053 |
| 541 |
DYSURIA |
196 |
0.0053 |
| 542 |
SKIN DISORDER |
176 |
0.0053 |
| 543 |
FATIGUE |
4107 |
0.0053 |
| 544 |
THERAPY CESSATION |
270 |
0.0053 |
| 545 |
MELAENA |
115 |
0.0052 |
| 546 |
STATUS EPILEPTICUS |
59 |
0.0052 |
| 547 |
ANGIOEDEMA |
231 |
0.0052 |
| 548 |
PULMONARY FIBROSIS |
100 |
0.0052 |
| 549 |
CARDIOMYOPATHY |
77 |
0.0052 |
| 550 |
ARTERIOSCLEROSIS |
49 |
0.0052 |
| 551 |
HYPOTHYROIDISM |
166 |
0.0052 |
| 552 |
BLOOD GLUCOSE ABNORMAL |
96 |
0.0052 |
| 553 |
NEUTROPHIL COUNT DECREASED |
211 |
0.0052 |
| 554 |
HYPERTRANSAMINASAEMIA |
36 |
0.0052 |
| 555 |
ENCEPHALOPATHY |
127 |
0.0052 |
| 556 |
BLOOD IRON DECREASED |
61 |
0.0051 |
| 557 |
ATAXIA |
61 |
0.0051 |
| 558 |
URINARY TRACT INFECTION |
876 |
0.0051 |
| 559 |
FAECES DISCOLOURED |
111 |
0.0051 |
| 560 |
DYSPHONIA |
299 |
0.0051 |
| 561 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
47 |
0.0051 |
| 562 |
TOOTH ABSCESS |
52 |
0.0051 |
| 563 |
ACIDOSIS |
39 |
0.0051 |
| 564 |
FUNGAL INFECTION |
170 |
0.0051 |
| 565 |
VOMITING |
2397 |
0.0051 |
| 566 |
DYSPNOEA |
2874 |
0.0051 |
| 567 |
HAEMORRHOIDS |
99 |
0.0051 |
| 568 |
RENAL FAILURE CHRONIC |
39 |
0.0051 |
| 569 |
PULMONARY EMBOLISM |
481 |
0.0051 |
| 570 |
EPILEPSY |
154 |
0.0050 |
| 571 |
WOUND INFECTION |
55 |
0.0050 |
| 572 |
TUBULOINTERSTITIAL NEPHRITIS |
94 |
0.0050 |
| 573 |
INCONTINENCE |
53 |
0.0050 |
| 574 |
MUSCULOSKELETAL PAIN |
261 |
0.0050 |
| 575 |
FACE OEDEMA |
84 |
0.0050 |
| 576 |
LEUKOCYTOSIS |
90 |
0.0050 |
| 577 |
MENTAL STATUS CHANGES |
138 |
0.0050 |
| 578 |
CENTRAL NERVOUS SYSTEM LESION |
68 |
0.0049 |
| 579 |
ACUTE MYELOID LEUKAEMIA |
77 |
0.0049 |
| 580 |
DEVICE RELATED INFECTION |
76 |
0.0049 |
| 581 |
HAEMATURIA |
169 |
0.0049 |
| 582 |
RASH |
2151 |
0.0049 |
| 583 |
PERITONITIS |
101 |
0.0049 |
| 584 |
APHONIA |
68 |
0.0049 |
| 585 |
PAIN IN JAW |
138 |
0.0049 |
| 586 |
HEPATIC ENZYME INCREASED |
329 |
0.0048 |
| 587 |
HAEMOLYTIC ANAEMIA |
43 |
0.0048 |
| 588 |
EAR INFECTION |
127 |
0.0048 |
| 589 |
DYSPHAGIA |
452 |
0.0048 |
| 590 |
FLATULENCE |
270 |
0.0048 |
| 591 |
OROPHARYNGEAL PAIN |
440 |
0.0047 |
| 592 |
DRY MOUTH |
385 |
0.0047 |
| 593 |
HEMIPARESIS |
80 |
0.0047 |
| 594 |
BONE DISORDER |
86 |
0.0047 |
| 595 |
METABOLIC ACIDOSIS |
150 |
0.0047 |
| 596 |
DISSEMINATED INTRAVASCULAR COAGULATION |
66 |
0.0047 |
| 597 |
BLISTER |
262 |
0.0047 |
| 598 |
GENERALISED TONIC-CLONIC SEIZURE |
77 |
0.0046 |
| 599 |
ABDOMINAL DISTENSION |
484 |
0.0046 |
| 600 |
WHITE BLOOD CELL COUNT DECREASED |
502 |
0.0046 |
| 601 |
SWOLLEN TONGUE |
144 |
0.0046 |
| 602 |
ACUTE HEPATIC FAILURE |
63 |
0.0046 |
| 603 |
GASTRIC HAEMORRHAGE |
53 |
0.0046 |
| 604 |
OFF LABEL USE |
4008 |
0.0046 |
| 605 |
ANAL INCONTINENCE |
41 |
0.0046 |
| 606 |
BLOOD COUNT ABNORMAL |
69 |
0.0045 |
| 607 |
LETHARGY |
261 |
0.0045 |
| 608 |
HYPOGLYCAEMIA |
220 |
0.0045 |
| 609 |
SPLENOMEGALY |
53 |
0.0045 |
| 610 |
APPENDICITIS |
42 |
0.0045 |
| 611 |
BLOOD GLUCOSE INCREASED |
846 |
0.0045 |
| 612 |
FOLLICULITIS |
47 |
0.0045 |
| 613 |
UPPER RESPIRATORY TRACT INFECTION |
207 |
0.0045 |
| 614 |
HYPERKALAEMIA |
157 |
0.0045 |
| 615 |
MALAISE |
1963 |
0.0045 |
| 616 |
HEPATOCELLULAR INJURY |
63 |
0.0044 |
| 617 |
SPUTUM DISCOLOURED |
42 |
0.0044 |
| 618 |
HEPATIC CIRRHOSIS |
83 |
0.0044 |
| 619 |
SKIN CANCER |
95 |
0.0044 |
| 620 |
PERIPHERAL COLDNESS |
60 |
0.0044 |
| 621 |
ABDOMINAL PAIN UPPER |
899 |
0.0044 |
| 622 |
HAEMORRHAGIC STROKE |
34 |
0.0043 |
| 623 |
HAEMATEMESIS |
110 |
0.0043 |
| 624 |
EOSINOPHIL COUNT INCREASED |
36 |
0.0043 |
| 625 |
SINUS TACHYCARDIA |
61 |
0.0043 |
| 626 |
MALIGNANT MELANOMA |
57 |
0.0043 |
| 627 |
SUDDEN DEATH |
45 |
0.0042 |
| 628 |
OSTEOMYELITIS |
77 |
0.0042 |
| 629 |
RASH GENERALISED |
110 |
0.0042 |
| 630 |
RESPIRATORY DISORDER |
127 |
0.0042 |
| 631 |
CYSTITIS |
135 |
0.0042 |
| 632 |
SECRETION DISCHARGE |
53 |
0.0042 |
| 633 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
71 |
0.0042 |
| 634 |
FULL BLOOD COUNT DECREASED |
85 |
0.0042 |
| 635 |
MYELODYSPLASTIC SYNDROME |
61 |
0.0042 |
| 636 |
HEMIPLEGIA |
35 |
0.0042 |
| 637 |
ABSCESS |
67 |
0.0042 |
| 638 |
LIP DRY |
38 |
0.0042 |
| 639 |
BLOOD PRESSURE ABNORMAL |
83 |
0.0042 |
| 640 |
PHARYNGITIS STREPTOCOCCAL |
45 |
0.0042 |
| 641 |
HYPERTENSIVE CRISIS |
46 |
0.0041 |
| 642 |
HAEMATOMA |
107 |
0.0041 |
| 643 |
CONSTIPATION |
899 |
0.0041 |
| 644 |
WOUND |
115 |
0.0041 |
| 645 |
END STAGE RENAL DISEASE |
75 |
0.0041 |
| 646 |
GINGIVAL BLEEDING |
56 |
0.0041 |
| 647 |
RHABDOMYOLYSIS |
170 |
0.0041 |
| 648 |
GOUT |
73 |
0.0041 |
| 649 |
NAUSEA |
3182 |
0.0040 |
| 650 |
ASPIRATION |
44 |
0.0040 |
| 651 |
HYPONATRAEMIA |
226 |
0.0040 |
| 652 |
TOOTH DISORDER |
89 |
0.0040 |
| 653 |
CHRONIC KIDNEY DISEASE |
304 |
0.0040 |
| 654 |
FLUID RETENTION |
203 |
0.0040 |
| 655 |
DISEASE RECURRENCE |
188 |
0.0039 |
| 656 |
HERPES ZOSTER |
227 |
0.0039 |
| 657 |
CHILLS |
462 |
0.0039 |
| 658 |
DRY SKIN |
524 |
0.0039 |
| 659 |
BACK PAIN |
905 |
0.0039 |
| 660 |
HEPATIC STEATOSIS |
72 |
0.0039 |
| 661 |
EAR PAIN |
75 |
0.0039 |
| 662 |
LIP SWELLING |
128 |
0.0038 |
| 663 |
FACIAL PAIN |
34 |
0.0038 |
| 664 |
BLOOD PRESSURE DECREASED |
253 |
0.0038 |
| 665 |
REBOUND EFFECT |
43 |
0.0038 |
| 666 |
PULMONARY HYPERTENSION |
79 |
0.0038 |
| 667 |
LOCAL SWELLING |
66 |
0.0038 |
| 668 |
GASTROINTESTINAL HAEMORRHAGE |
315 |
0.0038 |
| 669 |
INFLUENZA |
419 |
0.0038 |
| 670 |
GALLBLADDER DISORDER |
67 |
0.0037 |
| 671 |
RHINORRHOEA |
242 |
0.0037 |
| 672 |
SWELLING FACE |
243 |
0.0037 |
| 673 |
THROMBOSIS |
299 |
0.0037 |
| 674 |
NO THERAPEUTIC RESPONSE |
45 |
0.0037 |
| 675 |
ABNORMAL BEHAVIOUR |
146 |
0.0037 |
| 676 |
THERAPY INTERRUPTED |
263 |
0.0037 |
| 677 |
MOVEMENT DISORDER |
118 |
0.0037 |
| 678 |
TREATMENT FAILURE |
304 |
0.0037 |
| 679 |
KIDNEY INFECTION |
72 |
0.0037 |
| 680 |
PRURITUS GENERALISED |
79 |
0.0036 |
| 681 |
DEEP VEIN THROMBOSIS |
235 |
0.0036 |
| 682 |
FREQUENT BOWEL MOVEMENTS |
97 |
0.0036 |
| 683 |
WHITE BLOOD CELL COUNT INCREASED |
137 |
0.0036 |
| 684 |
ABDOMINAL PAIN LOWER |
90 |
0.0036 |
| 685 |
DIABETES MELLITUS INADEQUATE CONTROL |
63 |
0.0036 |
| 686 |
SWELLING |
332 |
0.0035 |
| 687 |
RENAL CANCER |
168 |
0.0035 |
| 688 |
DENTAL CARIES |
39 |
0.0035 |
| 689 |
SKIN DISCOLOURATION |
162 |
0.0035 |
| 690 |
HERNIA |
68 |
0.0035 |
| 691 |
HYPOKINESIA |
51 |
0.0035 |
| 692 |
COVID-19 |
615 |
0.0035 |
| 693 |
CHEST PAIN |
649 |
0.0035 |
| 694 |
BLOOD PRESSURE FLUCTUATION |
84 |
0.0035 |
| 695 |
MYELOSUPPRESSION |
126 |
0.0035 |
| 696 |
IMMUNE SYSTEM DISORDER |
46 |
0.0035 |
| 697 |
FEELING COLD |
97 |
0.0035 |
| 698 |
ABDOMINAL DISCOMFORT |
584 |
0.0035 |
| 699 |
PANCREATITIS ACUTE |
78 |
0.0035 |
| 700 |
FISTULA |
39 |
0.0035 |
| 701 |
PRODUCT USE ISSUE |
652 |
0.0035 |
| 702 |
POLLAKIURIA |
144 |
0.0034 |
| 703 |
NIGHT SWEATS |
111 |
0.0034 |
| 704 |
PNEUMONIA ASPIRATION |
86 |
0.0034 |
| 705 |
LIGAMENT SPRAIN |
34 |
0.0034 |
| 706 |
SHOCK |
79 |
0.0034 |
| 707 |
PANCREATITIS |
181 |
0.0034 |
| 708 |
PALLOR |
93 |
0.0034 |
| 709 |
RASH PRURITIC |
185 |
0.0034 |
| 710 |
HYPOACUSIS |
146 |
0.0034 |
| 711 |
BLOOD GLUCOSE FLUCTUATION |
37 |
0.0034 |
| 712 |
NEUROPATHY PERIPHERAL |
320 |
0.0034 |
| 713 |
MYOCLONUS |
40 |
0.0034 |
| 714 |
HAEMORRHAGE INTRACRANIAL |
50 |
0.0033 |
| 715 |
RETCHING |
71 |
0.0033 |
| 716 |
MYOCARDITIS |
38 |
0.0033 |
| 717 |
CYANOSIS |
52 |
0.0033 |
| 718 |
GASTROINTESTINAL DISORDER |
296 |
0.0033 |
| 719 |
PELVIC PAIN |
60 |
0.0033 |
| 720 |
FLUID OVERLOAD |
48 |
0.0033 |
| 721 |
CONJUNCTIVITIS |
61 |
0.0033 |
| 722 |
DRUG-INDUCED LIVER INJURY |
102 |
0.0032 |
| 723 |
CIRCULATORY COLLAPSE |
55 |
0.0032 |
| 724 |
HEART RATE DECREASED |
113 |
0.0032 |
| 725 |
HEPATIC CANCER |
77 |
0.0032 |
| 726 |
AMENORRHOEA |
56 |
0.0032 |
| 727 |
EYE INFECTION |
36 |
0.0032 |
| 728 |
SPEECH DISORDER |
167 |
0.0032 |
| 729 |
BLOOD GLUCOSE DECREASED |
153 |
0.0032 |
| 730 |
GASTROINTESTINAL PAIN |
35 |
0.0032 |
| 731 |
NASOPHARYNGITIS |
584 |
0.0032 |
| 732 |
OSTEONECROSIS |
104 |
0.0032 |
| 733 |
INJECTION SITE INDURATION |
41 |
0.0032 |
| 734 |
PHOTOSENSITIVITY REACTION |
52 |
0.0031 |
| 735 |
APHASIA |
95 |
0.0031 |
| 736 |
HEART RATE IRREGULAR |
71 |
0.0031 |
| 737 |
RIB FRACTURE |
64 |
0.0031 |
| 738 |
HYPERSOMNIA |
89 |
0.0031 |
| 739 |
OSTEOPENIA |
47 |
0.0031 |
| 740 |
BLOOD TEST ABNORMAL |
43 |
0.0031 |
| 741 |
DYSSTASIA |
89 |
0.0030 |
| 742 |
CEREBRAL HAEMORRHAGE |
109 |
0.0030 |
| 743 |
HYPOTENSION |
609 |
0.0030 |
| 744 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
76 |
0.0030 |
| 745 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
88 |
0.0030 |
| 746 |
INJECTION SITE MASS |
111 |
0.0030 |
| 747 |
SKIN REACTION |
42 |
0.0030 |
| 748 |
CYST |
37 |
0.0030 |
| 749 |
LOCALISED INFECTION |
72 |
0.0030 |
| 750 |
INTERNAL HAEMORRHAGE |
34 |
0.0030 |
| 751 |
THERAPEUTIC RESPONSE DECREASED |
180 |
0.0030 |
| 752 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
85 |
0.0029 |
| 753 |
RASH MACULO-PAPULAR |
65 |
0.0029 |
| 754 |
PAIN IN EXTREMITY |
860 |
0.0029 |
| 755 |
THIRST |
52 |
0.0029 |
| 756 |
JOINT INJURY |
62 |
0.0029 |
| 757 |
LIVER INJURY |
71 |
0.0029 |
| 758 |
JOINT SWELLING |
349 |
0.0029 |
| 759 |
ILLNESS |
295 |
0.0029 |
| 760 |
CARDIOGENIC SHOCK |
41 |
0.0029 |
| 761 |
ACUTE MYOCARDIAL INFARCTION |
84 |
0.0028 |
| 762 |
RESPIRATORY ARREST |
78 |
0.0028 |
| 763 |
CONFUSIONAL STATE |
457 |
0.0028 |
| 764 |
ANGINA PECTORIS |
81 |
0.0028 |
| 765 |
PAIN |
1735 |
0.0028 |
| 766 |
CHOKING |
55 |
0.0028 |
| 767 |
ERYTHEMA |
577 |
0.0028 |
| 768 |
EOSINOPHILIA |
49 |
0.0028 |
| 769 |
MUSCULOSKELETAL DISCOMFORT |
48 |
0.0028 |
| 770 |
SINUSITIS |
284 |
0.0028 |
| 771 |
HEART RATE INCREASED |
274 |
0.0028 |
| 772 |
HYPERTHYROIDISM |
40 |
0.0028 |
| 773 |
THYROID DISORDER |
42 |
0.0027 |
| 774 |
NERVOUS SYSTEM DISORDER |
85 |
0.0027 |
| 775 |
OXYGEN SATURATION DECREASED |
153 |
0.0027 |
| 776 |
DISORIENTATION |
107 |
0.0027 |
| 777 |
SKIN EXFOLIATION |
227 |
0.0027 |
| 778 |
CONTUSION |
259 |
0.0027 |
| 779 |
NASAL CONGESTION |
158 |
0.0027 |
| 780 |
EYE SWELLING |
100 |
0.0027 |
| 781 |
FLUSHING |
273 |
0.0027 |
| 782 |
TACHYCARDIA |
238 |
0.0027 |
| 783 |
BRONCHITIS |
198 |
0.0027 |
| 784 |
HAEMATOCHEZIA |
147 |
0.0027 |
| 785 |
DRUG INEFFECTIVE |
3509 |
0.0027 |
| 786 |
DIVERTICULITIS |
73 |
0.0026 |
| 787 |
MYALGIA |
447 |
0.0026 |
| 788 |
CEREBRAL INFARCTION |
64 |
0.0026 |
| 789 |
PRURITUS |
1002 |
0.0026 |
| 790 |
GAIT INABILITY |
87 |
0.0026 |
| 791 |
HAEMORRHAGE |
272 |
0.0026 |
| 792 |
SEASONAL ALLERGY |
36 |
0.0025 |
| 793 |
LABORATORY TEST ABNORMAL |
75 |
0.0025 |
| 794 |
PHARYNGEAL OEDEMA |
39 |
0.0025 |
| 795 |
TYPE 2 DIABETES MELLITUS |
85 |
0.0025 |
| 796 |
HEADACHE |
1580 |
0.0025 |
| 797 |
GAIT DISTURBANCE |
481 |
0.0025 |
| 798 |
MOOD ALTERED |
67 |
0.0025 |
| 799 |
OSTEOPOROSIS |
101 |
0.0025 |
| 800 |
HYPOAESTHESIA ORAL |
37 |
0.0025 |
| 801 |
NERVOUSNESS |
128 |
0.0024 |
| 802 |
PARALYSIS |
35 |
0.0024 |
| 803 |
LOWER RESPIRATORY TRACT INFECTION |
111 |
0.0024 |
| 804 |
PERICARDITIS |
41 |
0.0024 |
| 805 |
ARTHRALGIA |
1012 |
0.0024 |
| 806 |
HOT FLUSH |
183 |
0.0024 |
| 807 |
URINARY INCONTINENCE |
71 |
0.0024 |
| 808 |
URINARY RETENTION |
79 |
0.0024 |
| 809 |
CARDIOVASCULAR DISORDER |
60 |
0.0024 |
| 810 |
DELIRIUM |
82 |
0.0024 |
| 811 |
ATRIAL FIBRILLATION |
230 |
0.0024 |
| 812 |
LUNG NEOPLASM MALIGNANT |
97 |
0.0024 |
| 813 |
LIMB DISCOMFORT |
73 |
0.0024 |
| 814 |
ISCHAEMIC STROKE |
42 |
0.0024 |
| 815 |
MENSTRUATION IRREGULAR |
63 |
0.0023 |
| 816 |
ALOPECIA |
460 |
0.0023 |
| 817 |
CARDIAC FAILURE CONGESTIVE |
188 |
0.0023 |
| 818 |
AGGRESSION |
117 |
0.0023 |
| 819 |
PRODUCT AVAILABILITY ISSUE |
53 |
0.0023 |
| 820 |
PREMATURE DELIVERY |
37 |
0.0023 |
| 821 |
WHEEZING |
137 |
0.0023 |
| 822 |
DYSPEPSIA |
227 |
0.0023 |
| 823 |
ABASIA |
57 |
0.0023 |
| 824 |
SPINAL FRACTURE |
46 |
0.0023 |
| 825 |
DIABETIC KETOACIDOSIS |
55 |
0.0023 |
| 826 |
SLEEP DISORDER |
161 |
0.0023 |
| 827 |
CHEST DISCOMFORT |
233 |
0.0023 |
| 828 |
SNEEZING |
51 |
0.0023 |
| 829 |
FRACTURE |
43 |
0.0023 |
| 830 |
HOSPITALISATION |
349 |
0.0023 |
| 831 |
LYMPHOMA |
35 |
0.0023 |
| 832 |
RECTAL HAEMORRHAGE |
97 |
0.0023 |
| 833 |
POST PROCEDURAL COMPLICATION |
43 |
0.0022 |
| 834 |
CARDIO-RESPIRATORY ARREST |
93 |
0.0022 |
| 835 |
ERUCTATION |
43 |
0.0022 |
| 836 |
NECK PAIN |
124 |
0.0022 |
| 837 |
LACRIMATION INCREASED |
67 |
0.0022 |
| 838 |
CONDITION AGGRAVATED |
674 |
0.0022 |
| 839 |
CHROMATURIA |
50 |
0.0022 |
| 840 |
SYNCOPE |
220 |
0.0022 |
| 841 |
SCIATICA |
35 |
0.0022 |
| 842 |
MUSCULAR WEAKNESS |
249 |
0.0022 |
| 843 |
CARDIAC ARREST |
180 |
0.0022 |
| 844 |
NEPHROLITHIASIS |
100 |
0.0022 |
| 845 |
DRY EYE |
108 |
0.0022 |
| 846 |
UPPER LIMB FRACTURE |
43 |
0.0022 |
| 847 |
DIPLOPIA |
56 |
0.0022 |
| 848 |
DISCOMFORT |
131 |
0.0021 |
| 849 |
ALTERED STATE OF CONSCIOUSNESS |
46 |
0.0021 |
| 850 |
COMA |
101 |
0.0021 |
| 851 |
CORONARY ARTERY DISEASE |
64 |
0.0021 |
| 852 |
ARRHYTHMIA |
99 |
0.0021 |
| 853 |
ELECTROCARDIOGRAM QT PROLONGED |
74 |
0.0021 |
| 854 |
DIZZINESS |
1025 |
0.0021 |
| 855 |
RASH ERYTHEMATOUS |
98 |
0.0020 |
| 856 |
SKIN FISSURES |
40 |
0.0020 |
| 857 |
SCAR |
35 |
0.0020 |
| 858 |
INSOMNIA |
543 |
0.0020 |
| 859 |
DEAFNESS |
53 |
0.0020 |
| 860 |
BURNING SENSATION |
142 |
0.0020 |
| 861 |
BREAST CANCER FEMALE |
54 |
0.0020 |
| 862 |
HIP FRACTURE |
65 |
0.0020 |
| 863 |
PRODUCT PRESCRIBING ISSUE |
44 |
0.0020 |
| 864 |
GASTROOESOPHAGEAL REFLUX DISEASE |
162 |
0.0020 |
| 865 |
LACTIC ACIDOSIS |
65 |
0.0020 |
| 866 |
CATARACT |
119 |
0.0020 |
| 867 |
POOR QUALITY SLEEP |
43 |
0.0020 |
| 868 |
UNRESPONSIVE TO STIMULI |
51 |
0.0020 |
| 869 |
CONVULSION |
113 |
0.0020 |
| 870 |
FEELING ABNORMAL |
472 |
0.0020 |
| 871 |
INFLUENZA LIKE ILLNESS |
162 |
0.0020 |
| 872 |
PHOTOPHOBIA |
37 |
0.0020 |
| 873 |
FALL |
650 |
0.0020 |
| 874 |
EYE DISORDER |
64 |
0.0019 |
| 875 |
HYPERSENSITIVITY |
361 |
0.0019 |
| 876 |
DEPRESSED MOOD |
102 |
0.0019 |
| 877 |
TREMOR |
320 |
0.0019 |
| 878 |
HYPOAESTHESIA |
287 |
0.0019 |
| 879 |
LOSS OF CONSCIOUSNESS |
245 |
0.0019 |
| 880 |
ECZEMA |
100 |
0.0019 |
| 881 |
HEAD INJURY |
60 |
0.0019 |
| 882 |
AGRANULOCYTOSIS |
35 |
0.0019 |
| 883 |
LOWER LIMB FRACTURE |
36 |
0.0019 |
| 884 |
RENAL INJURY |
55 |
0.0018 |
| 885 |
NEURALGIA |
45 |
0.0018 |
| 886 |
CARDIAC DISORDER |
173 |
0.0018 |
| 887 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
333 |
0.0018 |
| 888 |
RASH PAPULAR |
41 |
0.0018 |
| 889 |
PREMATURE BABY |
55 |
0.0018 |
| 890 |
GASTRIC DISORDER |
61 |
0.0018 |
| 891 |
FEMUR FRACTURE |
55 |
0.0018 |
| 892 |
EXPOSURE DURING PREGNANCY |
110 |
0.0018 |
| 893 |
SINUS DISORDER |
35 |
0.0018 |
| 894 |
LIMB INJURY |
48 |
0.0018 |
| 895 |
INTENTIONAL PRODUCT USE ISSUE |
154 |
0.0018 |
| 896 |
INTERNATIONAL NORMALISED RATIO INCREASED |
50 |
0.0018 |
| 897 |
ROAD TRAFFIC ACCIDENT |
73 |
0.0017 |
| 898 |
PARAESTHESIA |
273 |
0.0017 |
| 899 |
MENORRHAGIA |
34 |
0.0017 |
| 900 |
OSTEOARTHRITIS |
73 |
0.0017 |
| 901 |
PRODUCT PRESCRIBING ERROR |
41 |
0.0017 |
| 902 |
ILL-DEFINED DISORDER |
104 |
0.0017 |
| 903 |
MEMORY IMPAIRMENT |
233 |
0.0017 |
| 904 |
PROCEDURAL PAIN |
47 |
0.0017 |
| 905 |
COGNITIVE DISORDER |
79 |
0.0017 |
| 906 |
SOMNOLENCE |
339 |
0.0017 |
| 907 |
URTICARIA |
280 |
0.0017 |
| 908 |
FEELING HOT |
102 |
0.0017 |
| 909 |
IRRITABILITY |
100 |
0.0017 |
| 910 |
DYSARTHRIA |
62 |
0.0016 |
| 911 |
WEIGHT INCREASED |
365 |
0.0016 |
| 912 |
AMNESIA |
106 |
0.0016 |
| 913 |
PSYCHOTIC DISORDER |
48 |
0.0016 |
| 914 |
AGITATION |
119 |
0.0016 |
| 915 |
MUSCLE SPASMS |
297 |
0.0016 |
| 916 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
64 |
0.0016 |
| 917 |
VERTIGO |
98 |
0.0016 |
| 918 |
ADVERSE DRUG REACTION |
142 |
0.0016 |
| 919 |
OCULAR HYPERAEMIA |
74 |
0.0016 |
| 920 |
CEREBROVASCULAR ACCIDENT |
262 |
0.0015 |
| 921 |
BLINDNESS |
63 |
0.0015 |
| 922 |
VISUAL IMPAIRMENT |
190 |
0.0015 |
| 923 |
THROAT IRRITATION |
68 |
0.0015 |
| 924 |
ANXIETY |
428 |
0.0015 |
| 925 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
106 |
0.0015 |
| 926 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
106 |
0.0015 |
| 927 |
CRYING |
54 |
0.0015 |
| 928 |
PALPITATIONS |
172 |
0.0015 |
| 929 |
MIGRAINE |
140 |
0.0015 |
| 930 |
MEDICATION ERROR |
81 |
0.0015 |
| 931 |
BALANCE DISORDER |
124 |
0.0014 |
| 932 |
MOBILITY DECREASED |
103 |
0.0014 |
| 933 |
DEMENTIA |
40 |
0.0014 |
| 934 |
PANCREATIC CARCINOMA |
41 |
0.0014 |
| 935 |
MYOCARDIAL INFARCTION |
246 |
0.0014 |
| 936 |
PRODUCT DOSE OMISSION |
92 |
0.0014 |
| 937 |
DEPRESSION |
320 |
0.0014 |
| 938 |
RASH MACULAR |
49 |
0.0014 |
| 939 |
SKIN IRRITATION |
64 |
0.0014 |
| 940 |
TREATMENT NONCOMPLIANCE |
76 |
0.0014 |
| 941 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
35 |
0.0014 |
| 942 |
HYPERHIDROSIS |
173 |
0.0013 |
| 943 |
PAIN OF SKIN |
36 |
0.0013 |
| 944 |
SURGERY |
77 |
0.0013 |
| 945 |
PLASMA CELL MYELOMA |
51 |
0.0013 |
| 946 |
DYSKINESIA |
53 |
0.0013 |
| 947 |
EMOTIONAL DISORDER |
40 |
0.0013 |
| 948 |
MOOD SWINGS |
41 |
0.0013 |
| 949 |
RESTLESSNESS |
44 |
0.0012 |
| 950 |
PRODUCT DOSE OMISSION ISSUE |
353 |
0.0012 |
| 951 |
VISUAL ACUITY REDUCED |
39 |
0.0012 |
| 952 |
VISION BLURRED |
159 |
0.0012 |
| 953 |
ANGER |
39 |
0.0012 |
| 954 |
MENTAL DISORDER |
50 |
0.0011 |
| 955 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
58 |
0.0011 |
| 956 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
223 |
0.0011 |
| 957 |
FOETAL EXPOSURE DURING PREGNANCY |
89 |
0.0011 |
| 958 |
ARTHRITIS |
85 |
0.0011 |
| 959 |
EYE PAIN |
60 |
0.0011 |
| 960 |
NO ADVERSE EVENT |
191 |
0.0011 |
| 961 |
ANAPHYLACTIC REACTION |
58 |
0.0010 |
| 962 |
ASTHMA |
118 |
0.0010 |
| 963 |
TRANSIENT ISCHAEMIC ATTACK |
34 |
0.0010 |
| 964 |
DISTURBANCE IN ATTENTION |
54 |
0.0010 |
| 965 |
ABORTION SPONTANEOUS |
40 |
0.0010 |
| 966 |
THERAPEUTIC RESPONSE UNEXPECTED |
44 |
0.0010 |
| 967 |
ADVERSE EVENT |
90 |
0.0010 |
| 968 |
ARTHROPATHY |
51 |
0.0009 |
| 969 |
MATERNAL EXPOSURE DURING PREGNANCY |
80 |
0.0009 |
| 970 |
INCORRECT DOSE ADMINISTERED |
199 |
0.0009 |
| 971 |
TINNITUS |
40 |
0.0009 |
| 972 |
BRADYCARDIA |
46 |
0.0009 |
| 973 |
HALLUCINATION |
64 |
0.0008 |
| 974 |
INJECTION SITE PAIN |
242 |
0.0008 |
| 975 |
MUSCULOSKELETAL STIFFNESS |
69 |
0.0008 |
| 976 |
PRODUCT SUBSTITUTION ISSUE |
44 |
0.0008 |
| 977 |
INJURY |
53 |
0.0008 |
| 978 |
PROSTATE CANCER |
59 |
0.0007 |
| 979 |
INJECTION SITE SWELLING |
55 |
0.0007 |
| 980 |
EYE IRRITATION |
41 |
0.0007 |
| 981 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
34 |
0.0007 |
| 982 |
UNEVALUABLE EVENT |
49 |
0.0006 |
| 983 |
SKIN BURNING SENSATION |
46 |
0.0006 |
| 984 |
UNDERDOSE |
44 |
0.0006 |
| 985 |
INFUSION RELATED REACTION |
36 |
0.0005 |
| 986 |
DRUG DOSE OMISSION |
87 |
0.0005 |
| 987 |
OVERDOSE |
99 |
0.0005 |
| 988 |
INTENTIONAL PRODUCT MISUSE |
37 |
0.0004 |
| 989 |
PRODUCT STORAGE ERROR |
34 |
0.0004 |
| 990 |
PSORIASIS |
47 |
0.0004 |
| 991 |
PRODUCT QUALITY ISSUE |
47 |
0.0003 |
| 992 |
INJECTION SITE ERYTHEMA |
40 |
0.0003 |